The Back and Forth on Open Access

After reading your article about open access1, the first thing that comes to mind is: What can I do to help this movement?I am a professor of Human Anatomy and Physiology and Exercise Physiology primarily involved in teaching. I often like to use examples of cutting-edge research in class. I come across many abstracts with relevant findings [but] I can't review the entire paper because my university doesn't have a subscription to that particular journal online. I find this appalling, especially

Written byFrank Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

After reading your article about open access1, the first thing that comes to mind is: What can I do to help this movement?

I am a professor of Human Anatomy and Physiology and Exercise Physiology primarily involved in teaching. I often like to use examples of cutting-edge research in class. I come across many abstracts with relevant findings [but] I can't review the entire paper because my university doesn't have a subscription to that particular journal online. I find this appalling, especially since I teach at a relatively large state institution. In such cases how am I expected to fork over the money to get this information (several hundred dollars per year for many subscriptions or, for example $30 for a paper)? The fact that most of the research is publicly funded makes matters worse. If anything, online subscriptions should be, at the most, dirt cheap: How difficult can it ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies